Lumen Metabolic Health Device Now Peer-reviewed
Lumen , a health tech company and the creators of the world's first portable metabolism measurement device, has officially been peer-reviewed and published in the Interactive Journal of Medical Research (I-JMR). In collaboration with San Francisco State University, Lumen has validated an ongoing study launched in 2020, which shows the validity of Lumen® to detect changes in metabolic fuel utilization in a comparable manner with a laboratory standard metabolic cart, providing the ability for real-time metabolic information for users under any circumstances.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210517005774/en/
Lumen now peer-reviewed (Photo: Business Wire)
Developed through years of scientific testing and validation, Lumen is the first handheld, portable device and app that measures your metabolism in real-time with just your breath.
The methodology behind the peer-reviewed validation of Lumen
The study compares the metabolic fuel measurement capabilities of the Lumen device to the gold standard measurement of metabolic carts. These measure the carbon dioxide and oxygen produced from the breath in order to assess metabolic fuel usage (carbohydrates vs. fats). Metabolic carts are known to be costly and only available to the public in laboratory settings.
Lumen has made metabolic testing accessible as the only handheld device available to measure your metabolism from home via the CO2 exhaled from the breath.
"We are thrilled the scientific community recognizes Lumen's ability to measure metabolic fuel utilization as effectively as the metabolic cart. This is groundbreaking because now metabolism measurement is accessible to all from home, rather than relying on solutions that are costly or time-consuming,” says Dr. Shlomo Yeshurun , Head of Research at Lumen.
Results using Lumen and the metabolic cart with young, healthy participants
Participants were young and healthy adults that measured their metabolism at a resting state and in two conditions: fasted and after consuming 150 grams of glucose.
Together with the values obtained from the metabolic cart and data from the Lumen device, changes in metabolic fuel usage were identified.
Both the RER and Lumen CO2 percentage increased significantly after glucose was consumed compared to the fasting state.
Another impactful result indicated that Lumen is in agreement with the gold-standard metabolic cart.
Lumen has the capability to provide accurate information regarding the metabolic state of individuals in agreement with results from the metabolic cart. For the first time, metabolic measurements can be performed from home without the constraints of a laboratory. What was once available only to athletes and medical professionals is now available to all consumers choosing the path to metabolic health.
Lumen plans to continue pioneering metabolic technology, data and knowledge through groundbreaking research and innovative technology to help people achieve optimal health.
The research behind metabolic flexibility
- Are at lower risk of developing obesity, diabetes and metabolic disorders.
- Are in a better position to gain muscle and perform better during workouts;
- Find it easier to lose weight and maintain it
Lumen helps people improve their health and fitness through technology on the forefront of personalized nutrition and metabolism. Conceived and designed by twin sisters, physiology PhDs and Ironman winners, Lumen harnesses the power of our breath to measure metabolism, which is closely linked to weight, fitness and personal health. The Lumen device measures metabolism in a single breath, in less than a minute, which previously was only possible through an hour-long lab test. Available at Lumen.me, Lumen devices ship globally, with the app available on the Apple App Store and Google Play. Lumen is headquartered in Israel, with offices in the United States.
The Lumen device is available at Lumen.me, currently priced at $299.
The device comes equipped with a travel case, charging dock, USB-C Cable, and Premium Customer Support. Users can download the app for free on the Apple App Store and on Google Play.
For media: images, video and fact sheet can be found in the press kit here.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Kyla Blumenfeld, email@example.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Druva Launches Industry’s First MSP Program with the Simplicity, Security, and Scale of a SaaS Platform23.6.2021 14:00:00 CEST | Press release
Druva Inc., the leader in Cloud Data Protection and Management, today announced the launch of its new Managed Service Provider (MSP) program. Part of the Druva Compass Partner Program, the new program is designed to empower MSPs and accelerate their customers’ cloud transformation with a resilient, simplified data protection service. Over the last 12 months, enterprises have accelerated and expanded the shift of operations to the cloud and according to a recent survey by Gartner, Inc., 68 percent of global respondents indicate that their organizations plan to increase spending on cloud computing in the next year.* MSPs are increasingly relied upon to help customers navigate these challenges, reduce operational complexity, and eliminate costly hardware. However, current data protection offerings demand significant infrastructure, requiring MSPs to make capital investments, manage complex environments, delay sales cycles, and compress operational margins. “Customers are moving to the clo
Sintavia Hires Brian Haggenmiller as Chief Financial Officer23.6.2021 13:59:00 CEST | Press release
Sintavia, LLC, a designer and 3D printer of a new generation of flight and launch components, announced today that it had hired Brian Haggenmiller as its new Chief Financial Officer. Mr. Haggenmiller had previously been the Senior Director of Financial Planning & Analysis at AerSale Corp., where he led that company’s financial planning efforts in advance of it going public in 2020 via a special purpose acquisition company. While at AerSale, Mr. Haggenmiller was also responsible for evaluating all types of commercial aerospace transactions, ranging from single engine deals to multiple aircraft packages. Mr. Haggenmiller holds a B.S. in Business Administration from Washington University’s Olin School of Business, and a Master of Business Administration from the University of Miami School of Business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005345/en/ (Photo: Business Wire) “We could not be more excited to have Bri
Chiesi Accelerates Path Toward Full Sustainability Despite Covid-19 Pandemic23.6.2021 13:39:00 CEST | Press release
Chiesi, the international research-focused pharmaceutical and healthcare Group (Chiesi Group), further accelerated its path toward becoming a fully sustainable company, despite an extremely challenging 2020, which was overshadowed by the Covid-19 pandemic. This is the thread running through Chiesi’s Annual & Sustainability Report 2020. The Group in 2020 turned in a robust financial performance, with revenues amounting to €2,229 million, up by 11.8% compared to 2019. It provides Chiesi with impetus to continue its transformational journey to become the world’s first fully sustainable pharmaceutical company, in which value generation for the planet and for society enables the creation of innovation, progress and prosperity. Transparent impact measurement methodology that integrates ESG (environmental, social, and corporate governance) topics and impact frameworks As in previous years, Chiesi is reporting how it operates in accordance with a comprehensive combination of multiple tools and
Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 202123.6.2021 13:00:00 CEST | Press release
Brii Biosciences (“Brii Bio”) and VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), today announced final results from a Phase 1b/2a study on BRII-179 (VBI-2601), a novel recombinant, protein-based immunotherapeutic candidate, in patients with chronic hepatitis B virus (HBV) infection. Data from the study, which evaluated the safety, antiviral activity, and immunogenicity of BRII-179 (VBI-2601) alone or admixed with interferon-alpha (IFN-α) as co-adjuvant, demonstrated that the investigational immunotherapeutic induced both B cell (antibody) and T cell responses, and was well-tolerated with no safety signals observed, in non-cirrhotic chronic hepatitis B patients under nucleos(t)ide analog (NUC) therapy. The study was led by Brii Bio in partnership with VBI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005322/en/ The data, as presented in a late-breaker e-Poster at the European Association for the Study of the Liver’s (EASL)
Amazon Becomes Largest Corporate Buyer of Renewable Energy in the U.S.23.6.2021 12:00:00 CEST | Press release
Amazon (NASDAQ: AMZN) today announced 14 new renewable energy projects in the U.S., Canada, Finland, and Spain to advance its ambitious goal to power 100% of company activities with renewable energy by 2025—five years ahead of the original target of 2030. The new projects bring Amazon’s total renewable energy investments to date to 10 gigawatts (GW) of electricity production capacity—enough to power 2.5million U.S. homes. Amazon is now the largest corporate buyer of renewable energy in the U.S. and the world. The latest utility-scale solar and wind projects will supply renewable energy for Amazon’s corporate offices, fulfillment centers, and Amazon Web Services (AWS) data centers that support millions of customers globally. These projects will also help Amazon meet its commitment to produce enough renewable energy to cover the electricity used by all Echo devices in use. These new projects support hundreds of jobs while providing hundreds of millions of dollars of investment in local c
Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System23.6.2021 12:00:00 CEST | Press release
Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today that it has raised $245 million in an oversubscribed and upsized Series D round, the largest private funding round for a dialysis device company in history. “We are delighted to attract such a strong syndicate of investors, which represents a clear vote of confidence in our innovative approach to dialysis treatment,” said John E. Milad, CEO of Quanta. “Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this mar
AntChain Launches Developer Support Program to Foster Global Collaboration on Blockchain and Other Innovations23.6.2021 10:50:00 CEST | Press release
AntChain, Ant Group’s technology brand, today launched a developer community support program at its first developer conference. The program is designed to further foster trusted industry collaboration networks with blockchain, secure computing, IoT, and other innovative technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210623005429/en/ Geoff Jiang, President of Ant Group’s Intelligent Technology Business Group (Photo: Business Wire) This new program will bring AntChain's technical know-how and industry experience to partners and developers across a variety of platforms. Among them, the AntChain open technology platform will serve to accelerate the development of blockchain applications as well as reduce costs, while the AntChain open business ecosystem will help connect partners and developers with complementary business opportunities and operational resources. A new talent certification system has also been put i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom